The Alpha-1 Channel

Alpha-1 All The Time!

Our Mission...

The Alpha-1 Foundation is dedicated to providing the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1 Antitrypsin Deficiency.

Q: What is Alpha-1?

A: A hereditary condition which can cause lung disease in adults and liver disease in people of all ages.

Showing posts with label Alpha-1 Antitrypsin Deficiency. Show all posts
Showing posts with label Alpha-1 Antitrypsin Deficiency. Show all posts

Alphas and carriers, now's the chance to be heard

A letter has been mailed to Alphas and Alpha-1 carriers across the United States, inviting them to answer a survey on the needs of the Alpha-1 community. The survey, a joint project of the Alpha-1 Foundation and Alpha-1 Association, asks for opinions on our programs and any unfilled needs. The survey will help both agencies to understand if Alphas are having problems accessing medical care, and also help us advocate for Alphas as health care reform continues.

The survey must be completed quickly: The deadline is Friday, Jan. 21.

The survey can be completed either online or, by request, on paper. For questions about the Alpha-1 community survey, contact Linda Rodriguez at lrodriguez@alpha-1foundation.org or 1-888-825-7421, Ext. 217.

Ed Brailey eulogized as an Alpha who "paid forward the gift of life" after lung transplant




Ed Brailey, nationally known Alpha-1 activist and leader, was buried Saturday morning with bagpipes playing in the background and a covering of new-fallen snow making the the burial site appear to be in the clouds. Burial was at East Lyme Cemetery, Connecticut.

He was remembered as a man “given eight extra years to be with all of us… he paid forward the gift of life many times over,” in the eulogy delivered by John Walsh, President & CEO of the Alpha-1 Foundation. “He’ll always be our inspiration and hero,” Walsh said.

Ed Brailey “in uniform” as leader of Team Brailey at the Escape to the Cape bike trek on Cape Cod, September, 2008.

Brailey died Jan. 3 in a hospital at the University of North Carolina in Chapel Hill. Brailey, 58, who received a single lung transplant at age 50 in 2002, had been hospitalized in December.
He had been a member of the Alpha-1 Association Board for five years and became Chair in 2010.

In Brailey’s honor, “Team Brailey” will lead Team Alpha-1 at the 2011 “Escape to the Cape” Bike Trek this fall, said Fred Walsh, longtime member of Team Alpha-1 and participant at the annual bike trek. “Team Alpha-1 will be calling itself the Brailey Brigade this year in Ed Brailey’s honor,” Walsh said.

“Ed was a dear friend to so many of us. In fact, probably most people that Ed ever met became his friend,” John Walsh had said after Brailey’s death. “He dedicated himself, many times at the risk of his own health, to help other Alphas in raising funds for a cure, creating awareness and providing the leadership to make a difference. Ed had ‘a fire inside’ and set an example for us all with his selfless commitment to the community. He was a passionate advocate and created a legacy of sharing and leading. We will miss our dear friend and we embrace JoAnne as her extended family. We will be here for her as Ed was here for all of us.”

Brailey was for many years a firefighter in his home town of East Lyme. After undergoing his lung transplant in May 2002, he became involved in fundraising efforts with “Team Brailey,” leading a team of firefighters, police officers and friends to many “Escape to the Cape” bike rides on Cape Cod, Massachusetts.

He and his friends also held events such as spaghetti dinners to raise funds for the Alpha-1 Foundation’s research programs.

He had served as the support group leader for the Alpha Nutmeggers of Connecticut for nearly a decade with the help of his wife JoAnne. The Braileys moved in 2010 to North Carolina.
The Braileys also raised funds for the Alpha-1 Association through spaghetti dinners, silent auctions, and raffles. He had been a frequent advocate in Washington for Alphas and others with rare and chronic diseases. He was also a long-time volunteer for the New England Organ Bank, and both Ed and JoAnne Brailey also served as volunteers for the COPD Foundation’s C.O.P.D. information line.


“Ed was a dedicated leader and renowned citizen of the Alpha-1 community,” said Marlene Erven, executive director of the Alpha-1 Association. “His mission in life was to improve the lives of Alphas. He loved being a peer guide to other Alphas and helping others in the community.”
When profiled in the Alpha-1 Foundation’s magazine in 2004, Brailey talked about his fundraising dinners. “People don’t come for the spaghetti,” he said. “They come for the cause. I can’t tell you how much that moves me.”


His first foray into fundraising came barely four months after his transplant. Five firefighter friends and two state troopers from Connecticut agreed to pedal in the “Escape to the Cape” bike trek in September. 2002.


“I took my wife’s Christmas card list and sent letters to friends, family members, and everyone we knew, telling them my story,” Brailey said. “I had to do something to give back what had been given to me. I was truly amazed by the response.”


He mailed nearly 400 letters, the team cycled 160 miles, and together they raised more than $20,000. “We sent all of the money we raised to the Foundation,” Brailey said. “One hundred percent of it went to research.”


He explained his attitude to an interviewer:“I got a transplant, but I’m still an Alpha. I still have this disease. There’s no way I’m going to turn my back on other Alphas. After I had my transplant, I wrote a letter to my donor’s family. I said, I know you’ve suffered a terrible loss. But I want you to realize the gift you’ve given me. I can play basketball with my grandkids. I will never take a gift like that for granted.”


In lieu of flowers, the family requested contributions to the Alpha-1 Foundation, 2937 SW 27th Avenue, Suite 302, Miami, Fl. 33133 or the Niantic Baptist Church, 443 Main St., Niantic, CT 06357.

State of Florida grants $1 million for lung transplant research center; Alpha doc Brantly directs research efforts


University of Florida News Service
Eight years ago, he sat in his living room, tethered to oxygen, his lungs rapidly deteriorating from pulmonary fibrosis. If Tom Telford had not become Patient No. 199, he probably would have gone on this way, unable to breathe, until he died.

That year, 2002, Telford became the 199th patient to receive a lung transplant at Shands at the University of Florida. He can’t run a marathon and struggles walking up a flight of stairs, but Patient No. 199 is alive. But for many lung transplant recipients, a successful transplant does not always ensure years of survival.

“At five years post-transplant, only 50 percent of recipients survive,” said Telford, a semi-retired nuclear engineer who lives in Gainesville. “I was No. 199. I knew 195 to 205. I exercised with these people and got to know them. Now, many of those people are not alive. It is pretty depressing.”

To help change these statistics, the state of Florida has awarded a $1 million grant to UF to establish a lung transplant center and fund research projects focused on problems such as chronic rejection, the most common reason why patients die after a lung transplant. The center emerged in 2010 from the flagship lung transplant program.

“Of the solid organ transplants, the survival rate of lung transplants is unfortunately the lowest,” said Mark Brantly, M.D., division chief of pulmonary medicine in the UF College of Medicine and a director of research efforts for the new lung transplant center. “There are many challenges in transplanting lungs not the least of which is chronic rejection. We are looking to develop a multicollege research group that will help advance our knowledge about rejection and will develop new therapeutics to improve our patients’ lives.”

Brantly also directs the Alpha-1 Research Program at the University of Florida.

Team Alpha-1 takes to the Cape again, wins Silver Spoke award and raises $60,000 for Alpha-1 research

Team Alpha-1 raised $60,000 for Alpha-1 research and brought home the “Silver Spoke Award” for the third year in a row at the team’s 15th consecutive ALA of Massachusetts Autumn Bike Trek—which everyone on the team calls the “Escape to the Cape.”

The event was held this past weekend, Oct. 1-3, on Cape Cod.

Team Alpha-1 consisted of 42 official riders and 48 volunteer supporters who helped with registration, sweeps, sag teams and medical support.

Participants in this “at-your-own pace” event, some of whom routinely ride with supplemental oxygen bottles carried on their bikes, had their choice of a two-day, 105-mile bike trek or three days and 160 miles along the Cape’s coast from Plymouth to Provincetown at the Cape’s northern tip.

Team Alpha-1 has won the annual “Silver Spoke” award for the largest team participating in the ride each of the three years the award has been offered. This year, riders came from New England, Colorado, Florida and New Jersey.

Sponsors of Team Alpha-1 are CSL Behring and Talecris Biotherapeutics, both of whom sent riders to participate.

See more photos HERE and HERE

Communications Update



Laura Fleming tells us what's new on the Foundation website and Facebook Page and let's you know why YOU need to be an Alpha Friend!

Foundation congratulates Baxter, Kamada on agreement to distribute augmentation therapy; hopes for closer relationship with community

MIAMI – The Alpha-1 Foundation today congratulated Baxter International and Kamada Ltd. on their new agreement for the distribution and manufacture of Kamada’s intravenous alpha-1 antitrypsin product Glassia for treatment of Alpha-1 Antitrypsin Deficiency.

Baxter will have exclusive rights to Glassia in the United States, Australia, New Zealand and Canada. Kamada, an Israeli biopharmaceutical company, developed Glassia, which was approved in July by the US Food and Drug Administration.

“We are pleased that Baxter, with its extensive experience in the Alpha-1 market, has contracted for the distribution,” said Foundation President & CEO John Walsh. “We are hopeful that this agreement will provide an opportunity for much closer cooperation with the Alpha-1 community. We also hope that this agreement will assist Kamada in accelerating the development of aerosolized therapy for Alpha-1.”

Walsh added that the Foundation has been closely involved with supporting the development of Alpha-1 augmentation therapies, clinical trial design and recruitment, with its clinical leadership and individuals in the Foundation’s Alpha-1 Research Registry

Download the full press release on our WEBSITE.

Team Harley Runs for a Cure

Owatonna People’s Press

OWATONNA, MN — In one respect, Team Harley’s goal was simple: All they wanted to do was finish the Owatonna Rotary/Steele County Free Fair 4-Mile Run. But there’s a lot more to it than that.

The family ran with the hope that dad and granddad Harley Janke will be well enough to see them cross the finish line next year, too.

To that end, they donned personalized T-shirts (emblazoned with “Run 4 Poppa”) and took to the road on Saturday.

CHECK OUT THE FULL STORY

Alpha-1 is solving crimes - on TV that is

Last week’s episode of the new TNT crime show Rizzoli & Isles features Alpha-1 Antitrypsin Deficiency.

In fact, Alpha-1 is the key to solving the crime.

Rizzoli & Isles is about the friendship between two women, Detective Jane Rizzoli and Coroner Maura Isles, and their teamwork in solving criminal cases.

The episode starring Alpha-1 is called “Money for Nothing”.

The eldest brother in a wealthy Boston family is found in the harbor dead after an apparent sailing accident. But this wouldn’t be a crime show if it didn’t turn out to be a murder.

And how does Alpha-1 come in?

Almost at the very end of the show, Isles reveals a fact that suggests a motive for murder—and proves that one of the “brothers” in the family wasn’t really a brother, after all.

One of the brothers had Alpha-1 Antitrypsin Deficiency (apparently a ZZ) and another brother had no Alpha-1 genes. So they couldn’t really be brothers, right?

An Alpha doc would likely find all this over-simplified, but hey, this is a TV drama. And Alpha-1 DOES get credit for helping to solve the crime. What more can we ask?

WATCH THE VIDEO

Foundation thanks Alphas for joining "Virtual Lobby Day"

Many Alphas from across the United States joined the first “Virtual Lobby Day” held by the American Association for Respiratory Care (AARC) Aug. 4.

On Virtual Lobby Day, patients and patient advocacy organizations joined respiratory therapists and other professionals to send personal messages to Congress. The focus of the messages was for Congress to support the Medicare Respiratory Therapy Initiative (HR 1077 and S 343).

These bills would provide for Medicare reimbursement for respiratory therapists working with physicians, but not necessarily under the physician’s direct supervision.

Alpha-1 Foundation President & CEO John Walsh expressed his personal thanks to the Alpha-1 community. “We are grateful for the participation and support of Alphas across the country in making Virtual Lobby Day a great success,” he said. “We are proud to support the expanded use of the skills of respiratory therapists, the health care professionals who have helped so many of us, often at critical moments in our health history.”

New Alpha-1 Foundation Video Blog

Ever wonder what it is that we all do at the Foundation?

What's going on in research?

Where are the upcoming events?

Got any new information available?

Well, now you can get an inside glimpse of our every day tasks, and keep up to speed with all our projects.

Welcome to: The Alpha-1 Channel - Alpha-1 all the time!

Our video blog (Vlog) will take you inside the Alpha-1 Foundation. Meet our staff, find out what's going on in your neighborhood, learn about what's new in our programs and send us your feedback.

We're glad to have you on board! Stay tuned!